Page 1 of 2
Sort by: Relevance | Date
This article is part of a Supplement: Volume 69 Supplement 1
This article is part of a Supplement: Volume 68 Supplement 1
The Correction to this article has been published in The Journal of Physiological Sciences 2018 69:s12576-018-0633-5
The Correction to this article has been published in The Journal of Physiological Sciences 2018 69:s12576-018-0624-6
This article is part of a Supplement: Volume 65 Supplement 1
This article is part of a Supplement: Volume 65 Supplement 1
This article is part of a Supplement: Volume 71 Supplement 1
This article is part of a Supplement: Volume 65 Supplement 1
This article is part of a Supplement: Volume 63 Supplement 1
This article is part of a Supplement: Volume 2017 Supplement 1
This article is part of a Supplement: Volume 65 Supplement 1
This article is part of a Supplement: Volume 64 Supplement 1
This article is part of a Supplement: Volume 59 Supplement 1
This article is part of a Supplement: Volume 6 Supplement 1
The Correction to this article has been published in Journal for ImmunoTherapy of Cancer 2019 7:46
This article is part of a Supplement: Volume 15 Supplement 2
The editors of BMC Musculoskeletal Disorders would like to thank all our reviewers who have contributed to the journal in Volume 16 (2015).
Radioisotope (RI) cisternography is considered to be the most important examination for the final diagnosis of intracranial hypotension, typically indicating cerebrospinal fluid (CSF) leakage as RI parathecal ...
The editors of BMC Gastroenterology would like to thank all our reviewers who have contributed to the journal in Volume 15 (2015).
Page kidney phenomenon is caused by strong renal parenchymal compression and leads to renal hypoperfusion and microvascular ischemia, resulting in renal dysfunction and hypertension. Although the development o...
The 30th summer school of the Research Community for Mechanisms of Mutations was held on September 2nd-3rd, 2017 at the Kyoto Prefecture Seminar House. The Community celebrated the 30th anniversary of the scho...
Lenvatinib is an oral inhibitor of multiple receptor tyrosine kinases (RTKs) targeting vascular endothelial growth factor receptor (VEGFR1-3), fibroblast growth factor receptor (FGFR1-4), platelet growth facto...
Patients with end-stage kidney disease (ESKD) face higher risks of life-threatening events including cardiovascular disease. Various risk factors are identified as agents influencing the life prognosis of ESKD...